Pharmaceutical Industry Information Portal

HomeNews

News

The clinical trial for an original Russian lung cancer drug has started in China

The BIOCAD and Shanghai Pharmaceuticals Holding joint venture has announced the enrollment of the first Chinese patient in the Phase III international multicenter clinical trial...

Russian Health Ministry recommends RA drug olokizumab for patients with COVID-19 of any severity

The Ministry of Health of the Russian Federation has issued the 12th version of the Temporary guidelines for the prevention, diagnosis and treatment of...

Promomed Group received approval for the first drug in its portfolio for treatment of HIV infection

Ritonavir, used for the treatment of HIV infection and viral hepatitis C, received the marketing authorization certificate and became the first drug in the...

Petr Bely: «State support of new markets will help to warm up domestic pharma»

«Pharmaceutical industry can and should be financially self-sufficient,» said Peter Bely, Chairman of the Board of Directors of Promomed Group at the «Strategy Implementation...

“Russian Big Pharma must do a 180 degree turn in its way of thinking” Vikram Punia says

A plenary session where Denis Manturov, Minister of Industry and Trade, and Mikhail Murashko, Minister of Health, participated focused on the issue of “Future...

The second joint laboratory of Promomed Group and Ogarev MSU is now officially opened

On September 30, with the support of Biokhimik JSC of Promomed Group, the scientific and educational laboratory for the synthesis of active pharmaceutical substances...
spot_img

Expert Articles

spot_img